go back

Melanoma Versus Benign Mole Gene Test

Hawaii rates for HCPCS 0314U

Helps decide whether a skin lesion is a melanoma or a harmless mole when its appearance under the microscope is not clear cut. The activity of 35 genes is measured in the stored tissue sample and the lesion is classified accordingly. A companion test instead judges the outlook for squamous cell skin cancers.

Rates data updated July 2026.

Facilitymedian $1,950 · 10th–90th $1,622$2,3440%20%40%10th90th$1,950Professionalmedian $2,188 · 10th–90th $1,950$2,4550%20%40%10th90th$2,188$1.0K$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$1,621.81
Median
$1,949.84
Typical High
$2,344.23
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,454.71
Median
$2,454.71
Typical High
$2,454.71
Cigna
Setting
Professional
Modifier
Global
Typical Low
$2,344.23
Median
$2,344.23
Typical High
$2,344.23
HMSA
Setting
Professional
Modifier
Global
Typical Low
$1,949.84
Median
$1,949.84
Typical High
$2,454.71
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$2,137.96
Median
$2,344.23
Typical High
$2,951.21
United
Setting
Professional
Modifier
Global
Typical Low
$977.24
Median
$1,949.84
Typical High
$2,344.23